Cabozantin Tablet

Cabozantin Tablet

(Cabozantinib)

Therapeutic Class:

Belongs to the therapeutic class of tyrosine kinase inhibitors(TKIs), Specifically a multitargeted TKI.

Generic Name:

Cabozantinib

Indication:

For:

  • Treating advanced Renal Cell Carcinoma (RCC), Help at cellular carcinoma(HCC), and differentiated Thyroid Cancer (DTC), often after prior treatments and also for certain Neuroendocrine Tumors(NETs).

Supplied as:

Tablet:

    • 20mg (10’s, 20’s,30’s,90’s)
    • 40mg (10’s, 20’s,30’s)
    • 60mg (10’s, 20’s,30’s)

Disclaimer:

Please consult your doctor before taking any medicine. To be sold only on prescription.